Gan Shmuel: Thailand as an Asian Shortcut or a Capital Layer That Still Needs Proof

The main article argued that Thailand is one of the critical proof points for 2026, but it left the central question open: what exactly has to be proved there. This follow-up isolates the Thai site itself, not all of Gan Shmuel and not the full concentrate cycle. The focus here is the new plant as a layer of strategy, capital and execution.

That matters now for a simple reason. On one hand, Thailand is no longer a concept. There is an operating company, a local partner, a built site, installed equipment, a license and an expanding workforce. On the other hand, as of year-end 2025, there is still no disclosure showing that the site is already delivering measurable sales, volumes or profitability. In other words, Thailand has passed the build test, but not yet the commercial proof test.

That is also the point a reader can easily miss by stopping at a comfortable headline like “entry into Asia.” Entry into Asia is not an accounting outcome. It has to end up as orders, sales, utilization, or at least a visible customer and volume layer. For now, the hard evidence only allows a narrower conclusion: Gan Shmuel has built a platform. It is still too early to say that the platform has already become operating value.

What Thailand Is Supposed to Be, and What It Is Not

Management’s framing is fairly clear. In the investor presentation, the company describes the Thai plant as a growth engine for new targets and as a way to enlarge the sales pie. In the strategy section of the annual report, the language is similar: Gan Shmuel wants to expand as an international supplier of food and beverage raw materials by using its Tailor Made capabilities, and TGS was established as part of that eastern expansion.

That is the core point. Thailand is not presented here as a hedge against the concentrate price cycle. It is presented as a shortcut to the market. The company is relying on a partner that had served for years as its agent in several Asian countries, and it turned that relationship into a joint venture meant to produce and market food and beverage raw materials in Asia. Operationally, the logic is proximity to the customer, a stronger customization layer, and a local combination of manufacturing, marketing and distribution.

But it is just as important to define what this site is not supposed to be. The annual report states explicitly that TGS is a concentrates-and-bases processing plant, not a fruit-processing plant. That distinction matters. The new site does not replicate the fruit intake and agricultural processing infrastructure that Gan Shmuel and Ganir run in Israel. It sits above that raw-material layer, not in place of it.

The analytical implication is straightforward. Thailand may be a very sound move, but it has to be measured against the right benchmark. The test is not whether a plant exists. The test is whether the plant is starting to move the revenue curve in Asia.

How Much Capital Is Already In, and How It Shows Up in the Accounts

Here the report is relatively direct. Under the founders’ agreement, the parties committed to pro rata funding and the provision of services to the venture. The company says it has invested $3.8 million in TGS and extended $1.6 million of shareholder loans. The commitments note adds that, at the full joint-venture level, total equity injected up to the report date reached about $4.7 million, while two shareholder loans totaled $2.0 million.

That means Thailand has already absorbed at least $5.4 million from Gan Shmuel itself. At the full project level, the capital layer already put in stands at about $6.7 million. This is no longer a cheap option on paper. It is a real capital commitment, even if it remains modest relative to the group balance sheet.

The more important point is how that investment appears in the accounts. In the balance-sheet review, management says property, plant and equipment rose 21.8% to $25.8 million, mainly because of fixed-asset purchases in the Thai subsidiary. In practical terms, Thailand entered the 2025 accounts first through the balance sheet. The money went into equipment, machinery, production lines and buildout well before it showed up in a sales line that can be analyzed.

The workforce layer tells the same story. At year-end 2025, TGS employed 12 permanent workers, up from 4 in 2024, and the company said it was still in the process of recruiting work teams. That is exactly what a ramping site looks like: headcount has moved up materially, but not yet to a level that naturally reads as a mature commercial operation.

In plain terms, Thailand has already cost much more than a token pilot, but the revenue side is still too thin to determine whether that capital is building value or simply deferring the real test into next year.

What Has Already Been Proved Operationally

Operationally, the company did move a long way in 2025. The plant structure was completed in the first quarter. On February 15, 2025, TGS signed a lease for industrial land and a building owned by a third party connected to the business partners, for an initial term of about three years from delivery, with renewal options. During the second and third quarters, most of the equipment, machinery and production lines were installed and tested, and on November 19, 2025 the company received an official food-manufacturing license from the Thai FDA.

The report even gives two complementary timing points on the finish line of the setup phase. In the commitments note, the company says the startup and ramp-up processes were expected to be completed during the first quarter of 2026. In the board report, the language moves one step further and says those processes were completed successfully during the first quarter of 2026. Together, those two statements tell the same economic story: by the report date, the site had already moved past construction and testing.

That matters because many industrial projects linger for years at the level of “under development.” Thailand is already beyond that. The problem is different now. The debate is no longer whether a site exists. It is whether a commercial engine exists.

What Still Has Not Been Proved

This is where the report becomes much quieter, and that silence is the heart of the thesis. There is no disclosure on TGS sales. There is no disclosure on actual production volume. There is no disclosure on customers onboarded through the site. There is no disclosure on utilization, gross margin, or orders signed because of it. Even the capacity figure disclosed in the annual report, estimated potential aggregate capacity of hundreds of tons per month, is explicitly labeled as a forward-looking estimate. It is not an operating result.

So as of year-end 2025 and the report date, Thailand is still a licensed capital-and-infrastructure layer, not a proved demand layer. The fact that the plant exists and the lines have been ramped is not the same as saying the business model has already been validated. That is exactly the mistake a reader can make by relying only on the strategy line.

It is also worth noticing the gap between the two stories management itself is telling. On one hand, the presentation describes 2025 as a year of sharp concentrate-price correction and softer demand. On the other hand, Thailand is framed as a site that should open new targets and expand the sales pie. By the company’s own framing, Thailand is not the direct answer to the 2025 price cycle. It is meant to add a new growth layer above it.

That distinction matters. Anyone looking to Thailand for an immediate fix to weak concentrate pricing or slower customer purchasing is assigning the project a role the company did not itself define. The real test is not whether Thailand cancels out the industry cycle. The real test is whether it adds a new regional engine while the industrial cycle is less supportive.

What Would Turn Thailand from Optionality into Operating Value

The first proof point now has to be commercial, not operational. Another statement about equipment, another photo of the line, or another sentence about progress would add little. What the market needs from here is sales, customers, volumes, or at least a clear indicator that the site has started carrying part of the company’s Asian activity.

The second proof point has to be qualitative. If management says Thailand is meant to strengthen the Tailor Made layer and the food-raw-material offering in Asia, readers need to see not only that the site can produce, but that it is producing in the places where customer proximity actually changes Gan Shmuel’s commercial proposition.

The third proof point has to be capital discipline. A project like this can still look attractive before it is profitable, but only as long as the investment layer remains proportionate to what is starting to come back from it. If 2026 brings another meaningful funding step without a first visible revenue contribution, Thailand will start to look less like a shortcut and more like a capital layer that keeps extending itself.

For now, the correct read on Thailand is a disciplined one. It is not a blind capital pit, because the site exists, has a license, has completed ramp-up, and rests on an established Asian partner. But it is not a success case either, because the report still does not show that the layer can move sales. Put differently, Thailand has already moved from idea to asset, but not yet from asset to engine.